Oramed Reports Third Quarter 2022 Financial Results
NEW YORK , Nov. 10, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (“Oramed” or the “Company”) (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today reported its financial results for the quarter
